Reviva Pharmaceuticals Holdings, Inc. (RVPH) Ownership
RVPH ownership summary
as of October 21, 2026- Institutions
- 8.2% of shares outstanding
- Insiders
- 7.73% of shares outstanding
- Shares outstanding
- 13.1M
- Float
- 11.9M shares available to trade
- Short interest
- 14.95% 1.9M shares short
- Days to cover
- 3.35 short interest up 30.5% vs prior month
- Institutions 8.24%
- Insiders 7.73%
- Other investors 84.04%
RVPH top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Highbridge Capital Management, LLC | 5.81% | 762K | $338,509 | +762,236 (0.0%) | March 31, 2026 |
| 2 | Armistice Capital, LLC | 4.52% | 592K | $262,942 | +592,079 (0.0%) | March 31, 2026 |
| 3 | Vanguard Capital Management, LLC | 0.90% | 118K | $52,212 | +117,568 (0.0%) | March 31, 2026 |
| 4 | Geode Capital Management, LLC | 0.56% | 73K | $32,416 | −975,962 (−93.0%) | March 31, 2026 |
| 5 | Renaissance Technologies Corp | 0.33% | 43K | $19,097 | +43,002 (0.0%) | March 31, 2026 |
| 6 | Virtu Financial LLC | 0.25% | 33K | $14,613 | +32,905 (0.0%) | March 31, 2026 |
| 7 | Vanguard Fiduciary Trust Co | 0.24% | 32K | $14,033 | +31,598 (0.0%) | March 31, 2026 |
| 8 | State Street Corp | 0.15% | 19K | $8,509 | −364,040 (−95.0%) | March 31, 2026 |
| 9 | BlackRock Inc | 0.14% | 19K | $8,252 | −353,079 (−95.0%) | March 31, 2026 |
| 10 | HRT FINANCIAL LLC | 0.14% | 18K | $8,182 | −12,689 (−40.8%) | March 31, 2026 |
| 11 | Northern Trust Corp | 0.08% | 10K | $4,649 | −198,904 (−95.0%) | March 31, 2026 |
| 12 | Morgan Stanley - Brokerage Accounts | 0.07% | 8,530 | $3,788 | −328,785 (−97.5%) | March 31, 2026 |
| 13 | EMC Capital Management(TX) | 0.05% | 6,696 | $2,974 | +250 (+3.9%) | June 30, 2026 |
| 14 | UBS Group AG | 0.04% | 5,269 | $2,340 | −354,186 (−98.5%) | March 31, 2026 |
| 15 | Vanguard Global Advisers, LLC | 0.02% | 3,115 | $1,383 | +3,115 (0.0%) | March 31, 2026 |
| 16 | Group One Trading, LLC | 0.02% | 3,109 | $1,381 | −9 (−0.3%) | March 31, 2026 |
| 17 | Tower Research Capital LLC | 0.02% | 2,193 | $974 | +2,193 (0.0%) | March 31, 2026 |
| 18 | Advisor Group Holdings, Inc. | 0.01% | 1,219 | $541 | +1,219 (0.0%) | March 31, 2026 |
| 19 | Larson Financial Group, LLC | 0.01% | 833 | $370 | −15,811 (−95.0%) | March 31, 2026 |
| 20 | TD Waterhouse Canada Inc | <0.01% | 625 | $278 | −11,870 (−95.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 1.6M shares and 10 cut 2.6M.
RVPH top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Extended Equity Market Fund E | 0.14% | 369K | $164,005 | +314,108 (+569.1%) | December 31, 2025 |
| 2 | Extended Equity Market Fund B | 0.14% | 369K | $164,005 | +314,108 (+569.1%) | December 31, 2025 |
| 3 | NT Ext Eq Mkt Idx Fd DC Lending Tier 5 | 0.03% | 3,618 | $1,607 | +25 (+0.7%) | March 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
RVPH insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2022-11-18 | Purav Patel | Buy | $4.69 | 3,000 | $14,070 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
RVPH shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns RVPH
Institutional investors own 8.2% of Reviva Pharmaceuticals's shares and insiders 7.73%. The largest holder is Highbridge Capital Management, LLC with 5.81% of the shares (762K), as of March 31, 2026. Among the top 20 institutions, 10 added shares and 10 reduced their stake in the latest filings. Short interest is 14.95% of the float, or 3.35 days of average trading volume. The share count rose 2,695.1% since 2018.
Related: RVPH analyst forecast, RVPH key metrics. See the RVPH stock overview for the latest quote and news.
RVPH ownership FAQ
Who owns the most Reviva Pharmaceuticals stock?
The largest shareholders of Reviva Pharmaceuticals are Highbridge Capital Management, LLC (5.81%), Armistice Capital, LLC (4.52%), Vanguard Capital Management, LLC (0.90%), Geode Capital Management, LLC (0.56%), Renaissance Technologies Corp (0.33%).
What percentage of Reviva Pharmaceuticals is owned by institutions?
Institutions hold 8.2% of Reviva Pharmaceuticals's shares outstanding; insiders hold 7.73%.
Which funds own Reviva Pharmaceuticals?
The largest fund holders of Reviva Pharmaceuticals are Extended Equity Market Fund E (0.14%), Extended Equity Market Fund B (0.14%), NT Ext Eq Mkt Idx Fd DC Lending Tier 5 (0.03%).
What is Reviva Pharmaceuticals's short interest?
1.9M shares of Reviva Pharmaceuticals were sold short, 14.95% of the float; at the average daily volume it would take 3.35 days to cover.
Are insiders buying or selling Reviva Pharmaceuticals?
Of the latest 1 reported insider transactions in Reviva Pharmaceuticals (since November 18, 2022), 1 were purchases and 0 were sales.
How many shares of Reviva Pharmaceuticals are outstanding?
Reviva Pharmaceuticals has 13.1M shares outstanding, of which 11.9M are in the public float.